Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. freshman Avg
|
|
New words:
ADC, addresse, adjourn, conjugate, depict, Ed, exemption, humanclinical, MCET, ouroperating, quorum, source, Steve, unvested
Removed:
accounted, al, anytime, began, bile, blood, Bot, breached, castle, CDR, charge, closed, complimentary, concert, creating, curative, diseased, doubtful, duct, encompassing, epitope, exhibiting, expired, expressly, extension, Fc, found, freestanding, hedging, Immunol, Immunotherapy, indexed, infection, inoperable, inside, interacted, intrahepatic, Japan, liquidation, liquidator, minimum, mixture, mouse, Mutual, myeloma, NCI, Nexavar, noncurrent, optimizing, peptide, preceding, processing, progressing, protective, ratified, receivable, reclassified, recombinant, region, renew, renewed, robust, settled, settlement, shifted, Sorafenib, stimulate, stronger, tolerization, unique, unit, unleash, vivo, warranted, XBRL
Filing tables
Filing exhibits
MCET similar filings
Filing view
External links
Exhibit 21.1
List of Subsidiaries
Xenogenics Corporation, a Nevada corporation (95.3% owned)
MultiCell Immunotherapeutics, Inc., a Delaware corporation (85.1% owned)